These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 38318504)

  • 21. High-resolution characterization of allelic and haplotypic HLA frequency distribution in a Spanish population using high-throughput next-generation sequencing.
    Montero-Martín G; Mallempati KC; Gangavarapu S; Sánchez-Gordo F; Herrero-Mata MJ; Balas A; Vicario JL; Sánchez-García F; González-Escribano MF; Muro M; Moya-Quiles MR; González-Fernández R; Ocejo-Vinyals JG; Marín L; Creary LE; Osoegawa K; Vayntrub T; Caro-Oleas JL; Vilches C; Planelles D; Fernández-Viña MA
    Hum Immunol; 2019 Jul; 80(7):429-436. PubMed ID: 30763600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies.
    O'Hanlon TP; Carrick DM; Targoff IN; Arnett FC; Reveille JD; Carrington M; Gao X; Oddis CV; Morel PA; Malley JD; Malley K; Shamim EA; Rider LG; Chanock SJ; Foster CB; Bunch T; Blackshear PJ; Plotz PH; Love LA; Miller FW
    Medicine (Baltimore); 2006 Mar; 85(2):111-127. PubMed ID: 16609350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linkage disequilibrium between HLA class II (DR, DQ, DP) and antigen processing (LMP, TAP, DM) genes of the major histocompatibility complex.
    Djilali-Saiah I; Benini V; Daniel S; Assan R; Bach JF; Caillat-Zucman S
    Tissue Antigens; 1996 Aug; 48(2):87-92. PubMed ID: 8883297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.
    Cromme FV; Airey J; Heemels MT; Ploegh HL; Keating PJ; Stern PL; Meijer CJ; Walboomers JM
    J Exp Med; 1994 Jan; 179(1):335-40. PubMed ID: 8270878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extended LTA, TNF, LST1 and HLA gene haplotypes and their association with rubella vaccine-induced immunity.
    Ovsyannikova IG; Vierkant RA; Pankratz VS; Jacobson RM; Poland GA
    PLoS One; 2010 Jul; 5(7):e11806. PubMed ID: 20668555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction and benchmarking of a multi-ethnic reference panel for the imputation of HLA class I and II alleles.
    Degenhardt F; Wendorff M; Wittig M; Ellinghaus E; Datta LW; Schembri J; Ng SC; Rosati E; Hübenthal M; Ellinghaus D; Jung ES; Lieb W; Abedian S; Malekzadeh R; Cheon JH; Ellul P; Sood A; Midha V; Thelma BK; Wong SH; Schreiber S; Yamazaki K; Kubo M; Boucher G; Rioux JD; Lenz TL; Brant SR; Franke A
    Hum Mol Genet; 2019 Jun; 28(12):2078-2092. PubMed ID: 30590525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered pattern of major histocompatibility complex expression in renal carcinoma: tumor-specific expression of the nonclassical human leukocyte antigen-G molecule is restricted to clear cell carcinoma while up-regulation of other major histocompatibility complex antigens is primarily distributed in all subtypes of renal carcinoma.
    Ibrahim EC; Allory Y; Commo F; Gattegno B; Callard P; Paul P
    Am J Pathol; 2003 Feb; 162(2):501-8. PubMed ID: 12547708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of heterozygosity at 6p21.3 underlying HLA class I downregulation in gastric cancer.
    Wang XC; Zhang JQ; Shen YQ; Miao FQ; Xie W
    J Exp Clin Cancer Res; 2006 Mar; 25(1):115-9. PubMed ID: 16761627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defective HLA Class I Expression and Patterns of Lymphocyte Infiltration in Chordoma Tumors.
    Patel SS; Nota SP; Sabbatino F; Nielsen GP; Deshpande V; Wang X; Ferrone S; Schwab JH
    Clin Orthop Relat Res; 2021 Jun; 479(6):1373-1382. PubMed ID: 33273248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Next-generation HLA typing of 382 International Histocompatibility Working Group reference B-lymphoblastoid cell lines: Report from the 17th International HLA and Immunogenetics Workshop.
    Creary LE; Guerra SG; Chong W; Brown CJ; Turner TR; Robinson J; Bultitude WP; Mayor NP; Marsh SGE; Saito K; Lam K; Duke JL; Mosbruger TL; Ferriola D; Monos D; Willis A; Askar M; Fischer G; Saw CL; Ragoussis J; Petrek M; Serra-Pagés C; Juan M; Stavropoulos-Giokas C; Dinou A; Ameen R; Al Shemmari S; Spierings E; Gendzekhadze K; Morris GP; Zhang Q; Kashi Z; Hsu S; Gangavarapu S; Mallempati KC; Yamamoto F; Osoegawa K; Vayntrub T; Chang CJ; Hansen JA; Fernández-Viňa MA
    Hum Immunol; 2019 Jul; 80(7):449-460. PubMed ID: 30844424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human Leukocyte Antigen (HLA) Class I and II Polymorphism in Iranian Healthy Population from Yazd Province.
    Nikbin B; Nicknam MH; Hadinedoushan H; Ansaripour B; Moradi B; Yekaninejad M; Aminikhah M; Ranjbar MM; Amirzargar A
    Iran J Allergy Asthma Immunol; 2017 Feb; 16(1):1-13. PubMed ID: 28417619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Haplotypic variation of the transporter associated with antigen processing (TAP) genes and their extension of HLA class II region haplotypes.
    Carrington M; Colonna M; Spies T; Stephens JC; Mann DL
    Immunogenetics; 1993; 37(4):266-73. PubMed ID: 8267790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA diversity, differentiation, and haplotype evolution in Mesoamerican Natives.
    Hollenbach JA; Thomson G; Cao K; Fernandez-Vina M; Erlich HA; Bugawan TL; Winkler C; Winter M; Klitz W
    Hum Immunol; 2001 Apr; 62(4):378-90. PubMed ID: 11295471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium.
    Chao MJ; Barnardo MC; Lui GZ; Lincoln MR; Ramagopalan SV; Herrera BM; Dyment DA; Sadovnick AD; Ebers GC
    Hum Mol Genet; 2007 Aug; 16(16):1951-8. PubMed ID: 17584771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterozygote advantage at HLA class I and II loci and reduced risk of colorectal cancer.
    Tsai YY; Qu C; Bonner JD; Sanz-Pamplona R; Lindsey SS; Melas M; McDonnell KJ; Idos GE; Walker CP; Tsang KK; Da Silva DM; Moratalla-Navarro F; Maoz A; Rennert HS; Kast WM; Greenson JK; Moreno V; Rennert G; Gruber SB; Schmit SL
    Front Immunol; 2023; 14():1268117. PubMed ID: 37942321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of HLA class I and class II alleles with bullous pemphigoid in Chinese Hans.
    Fang H; Shen S; Zheng X; Dang E; Zhang J; Shao S; Qiao P; Li Q; Wang H; Li C; Sun L; Wang G
    J Dermatol Sci; 2018 Mar; 89(3):258-262. PubMed ID: 29248402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TRBV and TRBJ usage, when paired with specific HLA alleles, associates with distinct head and neck cancer survival rates.
    Arndt MF; Koohestani DM; Chobrutskiy BI; Mihyu MM; Diaz M; Gozlan EC; Yeagley M; Zaman S; Roca AM; Blanck G
    Hum Immunol; 2020 Dec; 81(12):692-696. PubMed ID: 32950267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA class II immunogenetics and incidence of insulin-dependent diabetes mellitus in the population of Cantabria (Northern Spain).
    Escribano-de-Diego J; Sánchez-Velasco P; Luzuriaga C; Ocejo-Vinyals JG; Paz-Miguel JE; Leyva-Cobián F
    Hum Immunol; 1999 Oct; 60(10):990-1000. PubMed ID: 10566601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting Toxicity and Response to Pembrolizumab Through Germline Genomic HLA Class 1 Analysis.
    Iafolla MAJ; Yang C; Chandran V; Pintilie M; Li Q; Bedard PL; Hansen A; Lheureux S; Spreafico A; Razak AA; Hakgor S; Giesler A; Pugh TJ; Siu LL
    JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33554038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer.
    Koopman LA; Corver WE; van der Slik AR; Giphart MJ; Fleuren GJ
    J Exp Med; 2000 Mar; 191(6):961-76. PubMed ID: 10727458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.